Welcome to our dedicated page for Amrize SEC filings (Ticker: AMRZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Amrize Ltd (NYSE: AMRZ) SEC filings page on Stock Titan provides access to the company’s U.S. regulatory disclosures, including current reports on Form 8-K and other key documents. As a Switzerland-incorporated issuer listed on the New York Stock Exchange and the SIX Swiss Exchange, Amrize files reports with the U.S. Securities and Exchange Commission that give investors structured information about its operations and financial condition.
Recent Form 8-K filings from Amrize have reported quarterly financial results and related investor materials. These filings typically reference earnings press releases and investor presentations that discuss revenue by segment, non-GAAP metrics such as Adjusted EBITDA, Free Cash Flow, Net Debt and Net Leverage Ratio, and commentary on the performance of the Building Materials and Building Envelope segments. They also confirm details such as the company’s jurisdiction of incorporation in Switzerland and its principal executive office location in Zug.
On this page, investors can monitor new 8-K filings as they are released, along with other SEC forms when available, such as annual and quarterly reports that provide more comprehensive detail on Amrize’s business, risk factors and segment information. Filings related to capital structure, such as debt issuance, and any documents reporting significant events or transactions, are also part of the regulatory record.
Stock Titan enhances these filings with AI-powered summaries designed to explain the main points of lengthy documents in clear language. This can help readers quickly understand key topics such as segment performance, changes in leverage, major investments, or strategic initiatives like the ASPIRE program, while still allowing direct access to the full original filings for detailed analysis.
Amrize Ltd files its annual report as a newly independent, Switzerland‑based building solutions company focused on North America. It sells cement, aggregates, ready‑mix concrete, asphalt, and advanced roofing and wall systems through two segments: Building Materials and Building Envelope.
The company completed a spin‑off from Holcim on June 23, 2025 and now operates over 1,000 sites serving more than 23,000 customers, with over 19,000 employees across the United States, Canada, Colombia, Switzerland and Jamaica. As of December 31, 2025, Amrize had 553,082,525 Ordinary Shares outstanding, and non‑affiliate voting stock had an aggregate market value of about $27.4 billion as of June 30, 2025.
The report highlights opportunities from population growth, urbanization, infrastructure investment and acquisitions, but also detailed risks from construction cyclicality, inflation, energy and raw‑material costs, seasonality, regulation, environmental obligations, cybersecurity, labor relations, product liability and challenges realizing full benefits from the spin‑off.
Amrize Ltd reported essentially flat 2025 revenue but strong cash generation and a major capital return plan. Full-year revenues were $11.8 billion, up 0.9%, with net income of $1.2 billion and Adjusted EBITDA of $3.0 billion, both modestly below 2024. Free Cash Flow reached $1.5 billion and operating cash flow was $2.2 billion.
Building Materials drove growth, with 2025 revenues of $8.5 billion and fourth-quarter Segment Adjusted EBITDA up 5.9% on higher cement and aggregates volumes and pricing. Building Envelope revenues fell to $3.3 billion as softer residential roofing demand and higher warranty provisions weighed on margins, despite resilient commercial repair and refurbishment.
The balance sheet strengthened, with Net Debt of $3.3 billion and a Net Leverage Ratio of 1.1x as of December 31, 2025. The board approved a share repurchase authorization of $1.0 billion and is proposing both a $0.44 per share special one-time dividend and a $0.44 annual ordinary dividend. For 2026, Amrize guides revenues to $12.29–$12.52 billion and Adjusted EBITDA to $3.25–$3.34 billion, implying 4–6% and 8–11% growth respectively.
Amrize Ltd reported changes to its Board of Directors and Audit Committee following events on February 11, 2026. Theresa Drew stepped down from the Board, and the company states her resignation was not related to any disagreement over operations, policies, or practices.
On the same date, Robert S. Rivkin, who has served on the Audit Committee since June 2025, was appointed Chair of the Audit Committee. Holli Ladhani was appointed to the Audit Committee and designated as an “audit committee financial expert” under SEC rules and as meeting the NYSE’s financial literacy requirements.
Amrize Ltd reported receiving a Section 107(a) imminent danger order from the Mine Safety and Health Administration on February 5, 2026. The order stemmed from a third-party contract miner being exposed to a fall hazard by straddling a three-foot step ladder beyond its design capacity at the Ravena cement plant in New York. No injuries occurred as a result of this incident.
Amrize Ltd reported a mine safety incident at its Ravena cement plant in New York. On January 15, 2026, the company received an imminent danger order from the Mine Safety and Health Administration under Section 107(a) of the Federal Mine Safety and Health Act of 1977.
The order related to a third-party dump trailer driver who was exposed to a fall hazard while standing on the ladder rungs of a vehicle trailer. The company states that no injuries occurred as a result of this incident.
BlackRock, Inc. filed Amendment No. 2 to a Schedule 13G reporting beneficial ownership of 19,887,938 shares of Amrize Ltd common stock, representing 3.6% of the outstanding class as of the reporting date. BlackRock reports sole voting power over 18,280,793 shares and sole dispositive power over 19,887,938 shares, with no shared voting or dispositive power.
The filing reflects holdings by certain BlackRock business units and excludes any disaggregated units under SEC guidance. Various underlying persons may receive dividends or sale proceeds from these shares, but no single person has more than 5% of Amrize’s outstanding common stock. BlackRock certifies the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Amrize.
Amrize Ltd (AMRZ) director share purchase disclosed. A reporting person serving as a director of Amrize Ltd bought 2,000 ordinary shares on 11/19/2025 at a price of $47.34 per share in an open-market purchase coded "P." After this transaction, the director beneficially owns 4,958 ordinary shares held directly. The filing does not report any transactions in derivative securities.
Amrize Ltd (AMRZ) reported an insider purchase. An officer, President, Building Materials, acquired 4,000 ordinary shares on 11/04/2025 at $50.685 per share.
Following the transaction, the insider beneficially owned 18,101 shares, held directly. The filing was made by one reporting person on a Form 4.
Amrize Ltd (AMRZ) disclosed a Form 4 showing its Chief Technology Officer purchased a total of 4,000 ordinary shares on 10/31/2025 across two open‑market trades at $51.78 (3,000 shares) and $51.76 (1,000 shares). Following these transactions, the officer directly holds 9,000 shares.
The filing notes the trades were executed in Swiss Francs at CHF 41.51 and CHF 41.50 per share, converted using the transaction‑date exchange rate of USD 1.00 = CHF 0.8017.
Amrize Ltd (AMRZ) insider activity: On 10/30/2025, the company’s Chairman & CEO, who is also a Director, reported two open‑market purchases (Transaction Code P): 55,000 ordinary shares at a weighted average price of $52.64 (converted from CHF 42.05) and 55,000 ordinary shares at a weighted average price of $52.88. The purchases were executed in multiple trades within the stated price ranges.
Following these transactions, beneficial ownership was 1,505,000 shares held directly and 505,000 shares held indirectly by spouse.